Study guide
11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis
IJCAHPO Certified Ophthalmic Medical Technologist COMT
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements
1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification
2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology
2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway
3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety
3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety
4 Chapter 4: Ophthalmic History Taking & Clinical Documentation
4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record
5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision
5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction
6 Chapter 6: Tonometry, Keratometry & Pupil Measurement
6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria
7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis
7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment
8 Chapter 8: Refraction, Retinoscopy & Refinement
8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations
9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics
9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations
10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy
10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training
11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation
11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing
12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique
12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics
13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols
13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials
14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)
14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics
15 Chapter 15: Fluorescein Angiography Principles & Technique
15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management
16 Chapter 16: Angiographic Interpretation & Pathology
16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology
17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography
17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers
18 Chapter 18: Ophthalmic Photography & Videography
18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management
19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)
19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging
20 Chapter 20: Biometry, Topography & Corneal Analysis
20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth
21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting
21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems
22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications
22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis
23 Chapter 23: Ocular Pharmacology
23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF
24 Chapter 24: Microbiology & Ocular Specimen Collection
24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection
25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery
25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs
26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery
26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol
27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures
27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)
28 Chapter 28: Ophthalmic Patient Services & Education
28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support
29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance
29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements
11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis
Key Takeaways Explain This Topic AI
Humphrey visual field testing calibrates background luminance to 31.5 apostilbs (10 cd/m²) and uses a 200 ms stimulus presentation—shorter than the human 250 ms saccadic latency—to prevent refixation.
SITA Standard optimizes threshold determination using Bayesian likelihood models to cut test duration in half compared to Full Threshold, whereas SITA Faster reduces time by an additional 30% by eliminating false negative catch trials and blind spot checks.
False positive rates exceeding 15% indicate a 'trigger-happy' patient and invalidate the test by creating artificially elevated sensitivities ('white scotomas') and masking true defects.
Pattern Deviation plots filter out generalized depression (e.g., cataracts, miotic pupils, corneal edema) by adjusting the 85th percentile of sensitivity, isolating localized glaucomatous and neurological scotomas.
Pattern Standard Deviation (PSD) quantifies localized field irregularity; in advanced end-stage glaucoma, PSD paradoxically declines toward zero as total field extinction creates a uniformly depressed sensitivity map.
Last updated: September 2026
Automated Static Perimetry: HFA Strategies, Reliability Indices & Statpac Analysis
Core Clinical Mandate: Automated static perimetry is the clinical gold standard for the diagnosis, functional staging, and structural-functional correlation of glaucomatous optic neuropathy and neuro-ophthalmic pathways. The Certified Ophthalmic Medical Technologist (COMT) must possess mastery over the physical principles of bowl perimetry, the psychophysical algorithms governing threshold determination (SITA Standard, SITA Fast, SITA Faster), the critical thresholds of perimetric reliability, and the statistical deconstruction of Statpac single field printouts.
Physical Foundations & Optical Calibration of the Humphrey Field Analyzer
The Humphrey Field Analyzer (HFA) operates on the principles of static automated perimetry (SAP), wherein stationary light stimuli of variable luminance are projected onto a uniformly illuminated hemispherical bowl.
1. Bowl Dimensions & Background Luminance Calibration
Bowl Radius: Standardized at 30 cm , establishing a fixed optical vergence requiring appropriate near refractive correction in the trial lens holder.
Background Luminance: Calibrated strictly to 31.5 apostilbs (asb) , equivalent to 10 candelas per square meter (cd/m²) .
Physiological Rationale (Weber's Law): A background luminance of 31.5 asb positions the patient's retinal adaptation at the lower end of the photopic (light-adapted) to upper mesopic range . Within this physiological zone, the retina operates under Weber's law of contrast sensitivity : Δ I I = constant \frac{\Delta I}{I} = \text{constant} I Δ I = constant
Where Δ I \Delta I Δ I is the differential luminance threshold of the target and I I I is the background luminance. In this range, minor physiological fluctuations in pupil diameter or ambient illumination do not alter the differential threshold ratio, ensuring test reproducibility.
2. Stimulus Parameters: Duration & Goldmann Sizes
Stimulus Exposure Duration: Fixed at 200 milliseconds (0.20 seconds) . This duration is shorter than the human saccadic reaction latency (~250 ms). If a stimulus were presented for ≥ 250 ms \ge 250\text{ ms} ≥ 250 ms , the patient could initiate a refixation saccade to align their fovea with the peripheral target, invalidating peripheral threshold testing.
Stimulus Dimensions (Goldmann Size Hierarchy):
- Goldmann Size Surface Area (mm²) Angular Subtense (Degrees) Clinical Application
- Size 0 0.0625 (1/16) 0.054° (3.25') Experimental / Research
- Size I 0.25 (1/4) 0.108° (6.5') High-resolution macula
- Size II 1.00 0.216° (13') Mild central defects
- Size III 4.00 0.431° (26') Standard for SAP (all routine HFA tests)
- Size IV 16.00 0.862° (52') Low vision / severe loss
- Size V 64.00 1.724° (103') End-stage glaucoma, VA < 20/200, severe media opacity
Size III vs. Size V Clinical Transition: In advanced glaucoma where extensive absolute scotomas encompass the central 24° on a standard Size III stimulus, switching to a Goldmann Size V stimulus allows perimetrists to detect residual functioning retinal ganglion cell receptive fields that fall below the spatial summation threshold of Size III. Each step increase in Goldmann Roman numeral quadruples the target surface area ( 4 × 4\times 4 × ).
3. The Decibel (dB) Photometric Scale
The HFA measures threshold sensitivity in decibels (dB) , a logarithmic attenuation scale inversely related to physical stimulus brightness: dB = 10 ⋅ log 10 ( I max I ) \text{dB} = 10 \cdot \log_{10}\left(\frac{I_{\max}}{I}\right) dB = 10 ⋅ lo g 10 ( I I m a x )
Maximum Stimulus Intensity (0 dB): Unattenuated projector output equal to 10,000 apostilbs (asb) (3,183 cd/m²).
Decibel Attenuation: Each 10 dB represents a 1.0 log unit (10-fold) attenuation of light intensity.
30 dB Stimulus: Attenuated by 10 3 10^3 1 0 3 (1,000-fold), equivalent to 10 asb .
40 dB Stimulus: Attenuated by 10 4 10^4 1 0 4 (10,000-fold), equivalent to 1 asb .
0 dB (Absolute Scotoma): The brightest light the machine can project (10,000 asb) is not seen by the patient.
Normal Foveal Sensitivity: Typically ranges between 34 dB and 38 dB in healthy young observers.
Perimetric Testing Strategies: SITA Architecture
Historically, perimetry relied on the Full Threshold 4-2 staircase bracketing strategy , in which each retinal location was crossed twice with 4 dB and 2 dB steps, requiring 12 to 18 minutes per eye. The advent of the Swedish Interactive Threshold Algorithm (SITA) transformed visual field testing. Evolution of Automated Perimetry Strategies:
- Full Threshold (4-2 dB Staircase; 15 min/eye)
- │
- ▼
- SITA Standard (Bayesian Likelihood Models; 5-7 min/eye)
- │
- ▼
- SITA Fast (Wider Confidence Limits; 3-4 min/eye)
- │
- ▼
- SITA Faster (No Blind Spot/FN Catch Trials; 2 min/eye)
- 1. SITA Standard
Mathematical Engine: Utilizes dynamic Bayesian probability models based on extensive normative and glaucomatous visual field databases. The algorithm maintains a continuously updated probability distribution of threshold sensitivity for each test point.
Cross-Information Processing: Information gained at one test location immediately updates the prior probability distributions of neighboring points based on known receptive field clustering.
Real-Time Patient Pacing: Adjusts inter-stimulus intervals dynamically according to the individual patient's average reaction time.
Clinical Profile: Reduces test time to 4 to 7 minutes per eye while achieving diagnostic reproducibility identical or superior to the original Full Threshold strategy.
2. SITA Fast
Modifications: Utilizes wider confidence intervals for stopping rules and begins thresholding with fewer stimulus presentations per location.
Clinical Profile: Cuts test time to 2.5 to 4 minutes per eye . However, it exhibits slightly higher test-retest variability and slightly less sensitivity for early, shallow glaucomatous scotomas.
Indications: Pediatric patients, elderly individuals with poor endurance, physically debilitated patients, or those with severe fatigue artifacts on SITA Standard.
3. SITA Faster
Modifications (Introduced on HFA3):
Eliminates False Negative Catch Trials: Recognizes that false negative trials waste perimetric time and cause fatigue; instead, assesses response variability from the primary data stream.
Eliminates Heijl-Krakau Blind Spot Checks: Relies entirely on real-time infrared gaze tracking rather than flashing stimuli into the blind spot.
Optimized Starting Thresholds: Initiates testing at age-corrected normal sensitivity rather than 4 dB above threshold.
Clinical Profile: Reduces test time by another 30% (averaging 2 minutes per eye) . Highly effective for high-volume clinics, though baseline shifts must be accounted for when transitioning patients from SITA Standard to SITA Faster on Guided Progression Analysis (GPA).
Perimetric Test Grid Patterns
Selecting the correct test grid is critical to mapping specific visual pathway pathology:
1. The 30-2 Grid
Architecture: 76 test locations arranged in a 6° square grid covering the central 30° of the visual field.
The '-2' Configuration: Test points are offset by 3° from the horizontal and vertical meridians . This design ensures points straddle the meridians (e.g., at coordinates ( 3 , 3 ) , ( 3 , − 3 ) (3, 3), (3, -3) ( 3 , 3 ) , ( 3 , − 3 ) ), allowing clean detection of steps across the horizontal raphe and hemianopic vertical demarcations.
Limitation: The peripheral ring between 24° and 30° frequently displays false defects from the trial lens rim, ptotic upper eyelids, or prominent facial brow arches.
2. The 24-2 Grid
Architecture: 54 test locations spaced 6° apart. It completely eliminates the outermost ring of the 30-2 grid except on the nasal border , where two additional points extending to 30° are preserved.
Clinical Mandate: Preserving nasal points out to 30° is critical because early glaucomatous nerve fiber bundle loss preferentially produces a nasal step across the horizontal raphe. Eliminating the superior and temporal outer points removes 90% of trial lens rim artifacts and eyelid droop artifacts.
3. The 24-2C Grid
Architecture: Retains the 54 points of the 24-2 grid and adds 10 strategically placed central points within the central 10°.
Anatomical Rationale: Glaucoma is now recognized to cause early, focal macular ganglion cell loss in up to 16% of patients who appear normal or borderline on traditional 24-2 grids. The 24-2C detects these central defects without requiring a separate 10-2 test.
4. The 10-2 Grid
Architecture: 68 test points arranged in a dense 2° grid within the central 10° of fixation (straddling meridians by 1°).
Indications:
Advanced end-stage glaucoma to monitor central foveal-sparing islands.
Glaucomatous defects splitting fixation.
Hydroxychloroquine (Plaquenil) and chloroquine retinal toxicity surveillance (essential for detecting parafoveal scotomas).
Maculopathies (e.g., Stargardt disease, macular telangiectasia type 2, central serous chorioretinopathy).
Loading diagram... HFA Perimetric Reliability & Statpac Systematic Interpretation Algorithm
Perimetric Reliability Indices: Identification & Artifacts
Before interpreting any visual field scotoma, the technologist must rigorously audit the reliability indices located in the upper-left quadrant of the printout.
1. Fixation Losses (FL)
Heijl-Krakau Blind Spot Technique: At the beginning of the test, the machine plots the coordinates of the patient's physiological blind spot (typically centered at 15° temporal and 1.5° inferior to fixation). Throughout testing, the instrument projects a suprathreshold (Size III, 4 dB brighter than expected, or 0 dB) stimulus directly into this blind spot.
Criterion: If the patient presses the response button, the eye has drifted from fixation. A fixation loss rate > 20% is flagged with an 'x' on the printout and signals compromised reliability.
False Fixation Losses: Occur if the blind spot was improperly located at the start of the test (e.g., patient tilted head, or blind spot expanded by peripapillary atrophy or optic disc edema).
Real-Time Gaze Tracking: Displays an continuous infrared corneal-reflection tracing at the bottom of the printout:
Upward deflections: Represent gaze deviations (saccades away from the fixation target). The height of the deflection corresponds to the angular magnitude of the drift.
Downward deflections: Represent pupil occlusion (eyelid blinks, blepharoptosis, or head drooping).
2. False Positive (FP) Errors: The "Trigger-Happy" Patient
Mechanism: The instrument pauses stimulus projection or activates the mechanical projection shutter sound without illuminating a light target. If the patient presses the buzzer, a false positive error is recorded.
Diagnostic Threshold: False positive rates > 15% completely invalidate the visual field.
Clinical Manifestation:
The patient anticipates the rhythmic presentation of targets ("trigger-happy").
Generates abnormally elevated raw threshold values, often exceeding 45 to 50 dB (well beyond physiological human photoreceptor capacity).
Creates an artificially elevated Mean Deviation (MD can become positive, e.g., + 3.00 dB +3.00\text{ dB} + 3.00 dB ).
Generates the classic "white scotoma" artifact on Pattern Deviation plots, where the software overcompensates for the hyper-sensitive points and suppresses normal peripheral points.
3. False Negative (FN) Errors: Fatigue vs. Disease
Mechanism: The instrument projects a stimulus significantly brighter (typically 9 dB brighter ) than the previously established threshold at a location that has already demonstrated seeing ability.
Diagnostic Threshold: A rate > 25% to 33% is flagged on the printout.
Clinical Dual Etiology:
Patient Fatigue / Inattention: If FN is high in an otherwise normal visual field, it reflects drowsiness, drifting attention, or cognitive lapse. This typically generates a "cloverleaf" visual field artifact , in which the initial central quadrants tested have normal sensitivities, while the peripheral points tested later in the session are completely missed.
Severe Glaucomatous Damage: In eyes with moderate to advanced glaucomatous field loss, damaged retinal ganglion cells exhibit extreme biological threshold variability. A point may see a 12 dB stimulus on one pass and miss a 21 dB stimulus on the next pass. In an eye with an established dense arcuate defect, high FN is a marker of disease severity rather than poor testing effort .
4. Technical Artifacts
Trial Lens Rim Artifact: Occurs when the trial lens is placed too far from the eye (>15 mm) or decentered, creating a dense ring of peripheral depression resembling a 360° ring scotoma. Always verify trial lens centering.
Uncorrected Refractive Blur: Every 1.00 diopter of uncorrected spherical or cylindrical error causes approximately 1.25 dB of generalized sensitivity reduction .
Ptosis / Dermatochalasis: Superior drooping eyelids create pseudo-superior depression. If suspected, the test must be repeated with the upper eyelid taped securely to the orbital rim.
Statpac Single Field Analysis & Probability Maps
Statpac is the proprietary expert statistical package integrated into the Humphrey Field Analyzer that compares the patient's individual thresholds against an age-corrected normative database.
1. Raw Numerical & Grey Scale Displays
Raw Sensitivity Map: Shows the exact threshold measured in decibels (dB) at each retinal coordinate.
Grey Scale Map: Converts numerical dB values into shaded pixel patterns (from clear white for >35 dB to solid black for 0 dB). Clinical Rule: Never base a diagnostic decision on the grey scale alone! It exaggerates shallow depressions and masks early focal defects.
2. Total Deviation (TD) vs. Pattern Deviation (PD)
The core diagnostic engine of Statpac lies in the side-by-side comparison of Total Deviation and Pattern Deviation probability maps: Statpac Probability Map Comparison:
- ┌──────────────────────────────────────┐ ┌──────────────────────────────────────┐
- │ TOTAL DEVIATION (TD) │ │ PATTERN DEVIATION (PD) │
- │ │ │ │
- │ Measures total loss relative to │ │ Filters out generalized depression │
- │ age-matched normative database. │ │ (cataract, miosis, corneal haze). │
- │ Depressed by: │ │ Adjusts by 85th percentile shift │
- │ - Cataract / Media Opacity │ │ to isolate TRUE FOCAL DEFECTS. │
- │ - Uncorrected Refractive Error │ │ │
- │ - Glaucoma & Neurological Defects │ │ *PRIMARY DIAGNOSTIC PLOT* │
- └──────────────────────────────────────┘ └──────────────────────────────────────┘
Total Deviation (TD) Plot: Demonstrates the decibel difference between the patient's threshold at each point and the median value for age-matched normal individuals. Below the numerical grid, the probability plot assigns statistical significance symbols ( p < 5 % p < 5\% p < 5% , p < 2 % p < 2\% p < 2% , p < 1 % p < 1\% p < 1% , p < 0.5 % p < 0.5\% p < 0.5% ).
Pattern Deviation (PD) Plot: The most critical plot in automated perimetry. Statpac evaluates the overall height of the visual field by analyzing the 85th percentile of sensitivity (the 7th highest sensitivity point) . It then mathematically raises or lowers the entire field profile to correct for generalized depression (such as nuclear cataracts, posterior capsular opacification, corneal scars, or small pupils < 2.5 mm).
Diagnostic Rule of Thumb:
If the TD plot is heavily depressed but the PD plot is completely clear , the patient has pure generalized depression (e.g., dense cataract), not localized glaucomatous damage.
If the PD plot shows a cluster of significant points ( p < 1 % p < 1\% p < 1% or p < 0.5 % p < 0.5\% p < 0.5% ) respecting the horizontal raphe, the patient has true localized glaucomatous nerve fiber bundle loss , regardless of the appearance of the TD plot.
Global Indices & Longitudinal Progression Metrics
Statpac summarizes overall visual field performance into quantitative global indices:
1. Mean Deviation (MD)
Definition: The weighted average of all points on the Total Deviation plot compared to age-matched normal controls. Points closer to fixation are weighted slightly more heavily.
Polarity & Units: Expressed in decibels (dB) . Normal values range from 0.00 dB to -2.00 dB . A negative value indicates overall visual field depression below normal:
Mild Glaucoma: MD > − 6.00 dB \text{MD} > -6.00\text{ dB} MD > − 6.00 dB
Moderate Glaucoma: MD \text{MD} MD between − 6.00 dB -6.00\text{ dB} − 6.00 dB and − 12.00 dB -12.00\text{ dB} − 12.00 dB
Advanced / Severe Glaucoma: MD < − 12.00 dB \text{MD} < -12.00\text{ dB} MD < − 12.00 dB
Limitation: MD is non-specific; a patient with a mature cataract and zero glaucoma will exhibit a severely depressed MD of − 15.00 dB -15.00\text{ dB} − 15.00 dB .
2. Pattern Standard Deviation (PSD)
Definition: A measurement of the standard deviation of points from the overall hill of vision; it measures focal irregularity and contour non-uniformity across the visual field.
Clinical Significance: High PSD indicates localized scotomas (characteristic of early to moderate glaucoma, branch retinal vein occlusions, or localized neurological infarcts). A normal field or a field with pure dense cataract has a low PSD because the field is uniformly smooth.
The Terminal Glaucoma PSD Paradox: In end-stage glaucoma (MD < − 25 dB <-25\text{ dB} < − 25 dB ), PSD paradoxically decreases back toward normal levels (approaching 0 to 2 dB) . This occurs because the entire visual field is extinguished; when all test points drop to 0 dB, there is zero focal variance across the field!
3. Glaucoma Hemifield Test (GHT)
Algorithm: Compares visual sensitivity across the horizontal raphe by evaluating five mirrored sector pairs in the superior versus inferior visual hemifields (nasal, central arcuate, peripheral arcuate, paracentral, and central).
Diagnostic Output Categories:
Outside Normal Limits (ONL): Significant difference between superior and inferior sector pairs at the p < 1 % p < 1\% p < 1% level. Highly specific for glaucomatous nerve fiber loss.
Borderline: Sector differences significant at the p < 3 % p < 3\% p < 3% level.
General Reduction of Sensitivity: Overall field depressed without significant asymmetry between hemifields ( p < 0.5 % p < 0.5\% p < 0.5% ).
Abnormally High Sensitivity: Field sensitivities significantly higher than age-matched norms ( p < 0.5 % p < 0.5\% p < 0.5% ), almost invariably secondary to high false positives (>15%).
Within Normal Limits (WNL): No statistically significant asymmetry or depression.
4. Visual Field Index (VFI)
Definition: Introduced by Bengtsson and Heijl, VFI expresses the percentage of remaining visual field function adjusted for age, ranging from 100% (completely normal) to 0% (perimetrically blind) .
Key Advantages:
Calculated primarily from the Pattern Deviation plot , making it highly resistant to the confounding effects of progressive cataracts.
Centrally weighted: foveal and parafoveal points receive significantly higher mathematical weighting than peripheral points, matching the physiological density of retinal ganglion cells.
Used in Guided Progression Analysis (GPA) to calculate a linear regression rate of progression (% loss per year) and project future visual field loss over a 5-year timeline.